
PSYENCE BIOMEDICAL LTD
PBM · NASDAQ
Updated at 2026-11-16 21:36:43
- Today's High
- $3.13
- Today’s Low
- $2.66
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.14
- Previous Close
- $3.14
- Volume
- 43.25K
- Market Cap
- $11.99M
- P/E Ratio
- --
- EPS
- $-98.35
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 121 RICHMOND STREET WEST, TORONTO, ON, CANADA, M5H 2K1
- Country
- CA
- Listing Date
- 2021-12-10
- Fiscal Year End
- March
- Shares Outstanding
- 3.81M
- CIK
- 0001985062
- Website
- psyencebiomed.com/contact
Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental health and wellness challenges. The company employs a vertically integrated model, encompassing the cultivation, formulation, and clinical research of psilocybin and other psychedelics, which allows for thorough control over its product development processes. With a robust intellectual property portfolio and a progressive clinical pipeline, Psyence is strategically positioned to leverage the increasing acceptance of psychedelic therapies in the healthcare marketplace, aiming to deliver effective solutions that meet the urgent needs of patients.
Financial Metrics
Revenue
2025-09-30
$0
2024-12-31
--
2024-09-30
$0
2023-12-31
--
Operating Expenses
2025-09-30
$1.5M
2024-12-31
$1.15M
2024-09-30
$1.15M
2023-12-31
$632.1K
Net Income
2025-09-30
-$753.25K
2024-12-31
$141.47K
2024-09-30
$141.47K
2023-12-31
-$24.76M
Net Profit Margin
2025-09-30
--
2024-12-31
--
2024-09-30
--
2023-12-31
--
Earnings Per Share
2025-09-30
$-0.51
2024-12-31
$4.06
2024-09-30
$0.04
2023-12-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2025-09-30
-$749.16K
2024-12-31
$146.2K
2024-09-30
--
2023-12-31
-$632.05K
Effective Tax Rate
2025-09-30
--
2024-12-31
--
2024-09-30
--
2023-12-31
0%
| Item | 2025-09-30 | 2024-12-31 | 2024-09-30 | 2023-12-31 |
|---|---|---|---|---|
| Revenue | $0 | -- | $0 | -- |
| Operating Expenses | $1.5M | $1.15M | $1.15M | $632.1K |
| Net Income | -$753.25K | $141.47K | $141.47K | -$24.76M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.51 | $4.06 | $0.04 | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$749.16K | $146.2K | -- | -$632.05K |
| Effective Tax Rate | -- | -- | -- | 0% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.